NO20015295L - Pharmaceutical preparation in unit form containing acetylsalicylic acid and clopidogrel hydrogen sulfate - Google Patents

Pharmaceutical preparation in unit form containing acetylsalicylic acid and clopidogrel hydrogen sulfate

Info

Publication number
NO20015295L
NO20015295L NO20015295A NO20015295A NO20015295L NO 20015295 L NO20015295 L NO 20015295L NO 20015295 A NO20015295 A NO 20015295A NO 20015295 A NO20015295 A NO 20015295A NO 20015295 L NO20015295 L NO 20015295L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
unit form
hydrogen sulfate
acetylsalicylic acid
form containing
Prior art date
Application number
NO20015295A
Other languages
Norwegian (no)
Other versions
NO20015295D0 (en
Inventor
Bernard Abramovici
Jean Lheritier
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20015295D0 publication Critical patent/NO20015295D0/en
Publication of NO20015295L publication Critical patent/NO20015295L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20015295A 1999-04-30 2001-10-29 Pharmaceutical preparation in unit form containing acetylsalicylic acid and clopidogrel hydrogen sulfate NO20015295L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9905497A FR2792836B3 (en) 1999-04-30 1999-04-30 PHARMACEUTICAL COMPOSITION IN UNIT FORM CONTAINING ASPIRIN AND CLOPIDOGREL HYDROGENOSULFATE
PCT/FR2000/001086 WO2000066130A1 (en) 1999-04-30 2000-04-25 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate

Publications (2)

Publication Number Publication Date
NO20015295D0 NO20015295D0 (en) 2001-10-29
NO20015295L true NO20015295L (en) 2001-12-21

Family

ID=9545071

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015295A NO20015295L (en) 1999-04-30 2001-10-29 Pharmaceutical preparation in unit form containing acetylsalicylic acid and clopidogrel hydrogen sulfate

Country Status (24)

Country Link
EP (1) EP1178809A1 (en)
JP (1) JP2002543137A (en)
KR (1) KR20020005735A (en)
CN (1) CN1359294A (en)
AR (1) AR023789A1 (en)
AU (1) AU4303600A (en)
BR (1) BR0010194A (en)
CA (1) CA2371231A1 (en)
CZ (1) CZ20013887A3 (en)
EA (1) EA200100959A1 (en)
EE (1) EE200100559A (en)
FR (1) FR2792836B3 (en)
HK (1) HK1041823A1 (en)
HU (1) HUP0202329A2 (en)
IL (1) IL145648A0 (en)
IS (1) IS6084A (en)
MX (1) MXPA01011071A (en)
NO (1) NO20015295L (en)
NZ (1) NZ514248A (en)
PL (1) PL351923A1 (en)
SK (1) SK15542001A3 (en)
TR (1) TR200103039T2 (en)
UY (1) UY26131A1 (en)
WO (1) WO2000066130A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0400644A3 (en) 2000-12-25 2009-06-29 Ube Industries Pharmaceutical compositions containing aspirin
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
JP4917255B2 (en) * 2003-10-16 2012-04-18 第一三共ヘルスケア株式会社 Oral composition containing salicylic acids
WO2005070464A2 (en) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
CN101237868A (en) * 2005-06-13 2008-08-06 伊兰制药国际有限公司 Nanoparticulate clopidogrel and aspirin combination formulations
KR20070009851A (en) * 2005-07-14 2007-01-19 씨제이 주식회사 Pharmaceutical compositions containing clopidogrel bisulfate
CN101253179B (en) * 2005-09-21 2010-12-29 株式会社钟根堂 Novel resinate complex of S-clopidogrel and production method thereof
KR20070044323A (en) * 2005-10-24 2007-04-27 에스케이케미칼주식회사 Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate
US20100145053A1 (en) * 2006-04-05 2010-06-10 Cadila Healthcare Limited Modified release clopidogrel formulation
EP1900358A1 (en) * 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
HUP0600839A3 (en) * 2006-11-14 2008-09-29 Egis Gyogyszergyar Nyrt Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof
JP2011512406A (en) * 2008-02-22 2011-04-21 ハナル バイオファーマ カンパニー リミテッド Compound preparation
CN101695496A (en) * 2009-10-15 2010-04-21 苏春华 Medicinal composition containing triflusal and clopidogrel
JP2013032289A (en) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd Wax stable formulation
RU2484820C2 (en) * 2011-02-24 2013-06-20 Общество с ограниченной ответственностью "Озон" Combined medicine as thrombocyte aggregation inhibitor
KR101675501B1 (en) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 Combination of Clopidogrel and Aspirin
CN102406938A (en) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 Medicine composition for resisting thrombosis
JP6004524B2 (en) * 2012-07-11 2016-10-12 大原薬品工業株式会社 Method for producing clopidogrel sulfate-containing tablets
JP5905165B2 (en) * 2013-08-02 2016-04-20 サノフイ Pharmaceutical tablets containing acetylsalicylic acid and clopidogrel
CN104434932B (en) * 2014-12-18 2017-05-24 成都苑东生物制药股份有限公司 Pharmaceutical composition of clopidogrel hydrogen sulfate and acetylsalicylic acid tablet and preparation method thereof
WO2017037741A1 (en) * 2015-09-02 2017-03-09 Sun Pharmaceutical Industries Ltd Compact solid dosage form of aspirin and clopidogrel
CN115737578A (en) * 2022-11-23 2023-03-07 石家庄四药有限公司 Clopidogrel hydrogen sulfate and aspirin compound tablet and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (en) 1987-02-17 1992-01-24 Sanofi Sa ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
FR2744918B1 (en) 1996-02-19 1998-05-07 Sanofi Sa NEW COMBINATIONS OF ACTIVE INGREDIENTS CONTAINING THIENO (3,2-C) PYRIDINE DERIVATIVE AND AN ANTITHROMBOTIC
FR2779726B1 (en) 1998-06-15 2001-05-18 Sanofi Sa POLYMORPHIC FORM OF CLOPIDOGREL HYDROGENOSULFATE

Also Published As

Publication number Publication date
MXPA01011071A (en) 2002-07-22
CZ20013887A3 (en) 2002-02-13
JP2002543137A (en) 2002-12-17
IL145648A0 (en) 2002-06-30
IS6084A (en) 2001-09-25
CA2371231A1 (en) 2000-11-09
EE200100559A (en) 2003-02-17
PL351923A1 (en) 2003-06-30
KR20020005735A (en) 2002-01-17
FR2792836B3 (en) 2001-07-27
EA200100959A1 (en) 2002-06-27
BR0010194A (en) 2002-02-13
WO2000066130A1 (en) 2000-11-09
HUP0202329A2 (en) 2002-10-28
AR023789A1 (en) 2002-09-04
FR2792836A1 (en) 2000-11-03
AU4303600A (en) 2000-11-17
UY26131A1 (en) 2000-12-29
NZ514248A (en) 2003-06-30
CN1359294A (en) 2002-07-17
SK15542001A3 (en) 2002-02-05
HK1041823A1 (en) 2002-07-26
EP1178809A1 (en) 2002-02-13
TR200103039T2 (en) 2002-01-21
NO20015295D0 (en) 2001-10-29

Similar Documents

Publication Publication Date Title
NO20015295L (en) Pharmaceutical preparation in unit form containing acetylsalicylic acid and clopidogrel hydrogen sulfate
NO2020019I1 (en) Maraviroc optionally in the form of a pharmaceutically acceptable salt
DK1354888T3 (en) Glucopyranosyloxypyrazole derivatives and their use in drugs
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
IS6205A (en) Pharmaceutical and nutritional formulations containing essential fatty acids and homocysteine-lowering agents
NO20012245L (en) Anthranilic acid amides and their use as medicaments
NO20013302L (en) Medicinal product containing an opioid and an <alfa> agonist
NO20020374D0 (en) Carboxylic acid amides, drugs containing these compounds, their use and preparation
HK1052534A1 (en) 3-hydroxycarboxylic acid production and use in branched polymers
NO20010078L (en) Phenoxyacetic acid derivative and pharmaceutical composition comprising the same
DK200300344U1 (en) Amlodipine maleate and pharmaceutical composition containing amlodipine maleate
HUP0200386A2 (en) Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use
NO20034778L (en) Pharmaceutical compositions for oral and topical use
NO20024994L (en) Powder containing conjugated linoleic acid
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
PL395021A1 (en) Agents containing carboxylic acid and their application in plant cultivation
NO20030156D0 (en) Pharmaceutical compositions and methods for their use
AU2003278673A8 (en) Container with acid diffusion barrier and use thereof
DE60006625D1 (en) Controlled release composition containing 5-isosorbide nitrate and acetylsalicylic acid
NO20042380L (en) Pharmaceutical preparation comprising factor VII polypeptides and factor V polypeptides
EE200100607A (en) Pharmaceutical composition in granular form and a process for its preparation
FI974610A0 (en) Pharmaceutical preparations in gelform
GB0007788D0 (en) Method to evaluate the therapeutic and toxic effects related to drug administration
GB2381934B (en) Improvements in and relating to devices for storage
DK1272499T3 (en) Pharmaceutical compositions containing oligosaccharides and their preparation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application